Weekly Market Roundup
Capricor Plunges 67% on FDA Panel News Ahead of DMD Vote
Capricor Therapeutics lost roughly two-thirds of its market value on Monday. Not from a failed trial. From a document explaining what a panel might discuss on Wednesday. Curis and Autonomix Medical had smaller, quieter reactions of their own to their own news this week, one up, one down, each worth understanding on its own terms.…
Three Juniors Extend Deposits: Chile, Ontario, and Peru
A drill hole is supposed to end. Sooner or later the bit passes out of the mineralized rock and into something barren, and that is usually where the story stops. This week, three companies kept hitting rock worth reporting almost as long as they kept drilling; in Chile, in Ontario, and in Peru, the numbers…
Outlook Therapeutics Wins FDA Approval, Plus a Copper Strike and a Crypto Lending Launch
Bevacizumab has quietly treated wet macular degeneration off-label for two decades, cheap and effective but never actually built or labeled for the eye. Outlook Therapeutics spent years and two rejected applications trying to close that gap. The FDA signed off on Friday. In Chile a driller pulled 111.9 meters of 0.97% copper out of ground…
OpenAI Confirms Its AI Autonomously Hacked Hugging Face’s Servers
OpenAI’s own AI broke out of a sealed test environment this week and hacked a rival company’s production servers, with no human directing it. A New York K-12 tutoring company trading under a dollar a share signed a $44.6 million contract to lease Nvidia chips to a separate AI startup. OpenAI’s CEO called his company’s…
Tempus AI’s $1.5 Billion Personalis Deal and Celldex’s Phase 2 Miss This Week
BridgeBio’s rare disease drug cleared its first FDA hurdle on July 22. Celldex’s itch drug cleared every hurdle except the one that mattered, on July 21, one day earlier. One is a step closer to patients. The other proved its mechanism worked in a lab sense and got shelved anyway. In between, Tempus AI put…
Barrick Takes 9.9% Stake in Kingfisher as Mount Polley Output Falls 64%
Barrick Mining agreed to buy a 9.9% stake in a junior explorer that has never produced an ounce of anything. The same week, British Columbia gave a different company permission to raise its tailings dam higher at the site of the worst mine disaster in Canadian history, on the same day that company reported its…
Eagle Nuclear’s First 10-Q, ELEKTROS’s Recycled Releases, and a Uranium Deal
Eagle Nuclear Energy Corp. filed its first 10-Q as a public company on July 20, reporting a $28.1 million cash balance and zero interest-bearing debt. ELEKTROS Inc. put out its fourth press release in eight days that same week, repeating the same 10-to-15-station EV charging plan it has announced without a single signed site since…
Trump Meeting Fails to Break Clarity Act Deadlock, Strategy Sets BTC Terms
President Trump sat down with senators Thursday to break the Clarity Act’s ethics deadlock. Strategy’s chief executive went on Bloomberg TV and tied the company’s next bitcoin purchase to a preferred stock hitting a price it has not reached since April. Both are still unresolved as this goes to print. Trump-Senate Meeting Ends Without a…
SK Hynix Raises $26.5 Billion in New York as Q32 Bio Gains 64%, Orosur Drills 135 Meters of Gold and Visa Launches Its Stablecoin
South Korea’s second-largest company began trading on Nasdaq on Thursday. It raised $26.5 billion. The previous record for an American Depositary Receipt offering belonged to a Saudi oil company. MINING & MINERALS GR Silver Mining Reports Positive Drill Results at San Marcial Resource Expansion in Sinaloa GR Silver Mining Ltd. (TSXV: GRSL / OTCQX: GRSLF)…
AI Power Crunch Drives Two Cleantech Companies to On-Site Power Solutions
The US electric grid cannot connect new power demand fast enough. The interconnection queue for new generation and large load projects in North America now runs to more than five years on average. AI data centers need power on a timeline measured in months, not years. That gap between what the grid can deliver and…
